We are thrilled to announce that Vaccine Research, Development, and Innovation Co. (Vaccine RDI) has signed a Memorandum of Understanding (MoU) with the esteemed King Abdulaziz City for Science and Technology (KACST). This landmark partnership, sealed on October 22, 2024, marks a new chapter in advancing scientific research, technological innovation, and pharmaceutical development.

Key Highlights of the Collaboration:
• Establishing a national research laboratory focused on vaccine and biopharmaceutical development.
• Leveraging the expertise of KACST’s renowned researchers to support cutting-edge research.
• Promoting technology transfer and localizing pharmaceutical manufacturing to enhance Saudi Arabia’s pharmaceutical security.
• Creating training opportunities for scientists and supporting pharmaceutical entrepreneurs.
• Joint scientific projects that aim to boost innovation and contribute to global health solutions.

This agreement is a testament to our shared commitment to advancing healthcare solutions that contribute to the Kingdom’s strategic goals for sustainable development. Together, we are ready to make a lasting impact on global health and pharmaceutical innovation.

Stay tuned for updates on the exciting progress of this collaboration!